Christian P. Kratz

Carl Neuberg Str. 1
Hannover, NI 30625, Germany

Last Updated: 09/26/2026

Save publications for later

Sign Up

Not sure about your diagnosis?

Check Your Symptoms

Found 165 publications

Tumor patterns and cancer risk in carriers of TP53 exonic germline variants that alter mRNA splicing.

Tumor patterns and cancer risk in carriers of TP53 exonic germline variants that alter mRNA splicing.

Journal: European journal of human genetics : EJHG

Published: November 12, 2025

Urgent need to recognize that Disease-Causing TP53 variants with atypical penetrance require distinct clinical recommendations.

Urgent need to recognize that Disease-Causing TP53 variants with atypical penetrance require distinct clinical recommendations.

Journal: Journal of the National Cancer Institute

Published: October 20, 2025

Investigation of DNA Damage Response Genes Validates the Role of DNA Repair in Pediatric Cancer Risk and Identifies SMARCAL1 as a Novel Osteosarcoma Predisposition Gene.

Investigation of DNA Damage Response Genes Validates the Role of DNA Repair in Pediatric Cancer Risk and Identifies SMARCAL1 as a Novel Osteosarcoma Predisposition Gene.

Journal: Journal of clinical oncology : official journal of the American Society of Clinical Oncology

Published: October 09, 2025

A brief feasibility report on an online psychosocial support intervention for adults with Li-Fraumeni syndrome.

A brief feasibility report on an online psychosocial support intervention for adults with Li-Fraumeni syndrome.

Journal: Frontiers in psychology

Published: August 18, 2025

Neoantigenic properties of TP53 variants influence cancer risk in individuals with Li-Fraumeni syndrome.

Neoantigenic properties of TP53 variants influence cancer risk in individuals with Li-Fraumeni syndrome.

Journal: EBioMedicine

Published: August 07, 2025

Analysis of BRCA1, BRCA2 and PALB2 related Fanconi anemia identifies scope to expand disease phenotypic features and predict breast cancer risk in heterozygotes.

Analysis of BRCA1, BRCA2 and PALB2 related Fanconi anemia identifies scope to expand disease phenotypic features and predict breast cancer risk in heterozygotes.

Journal: medRxiv : the preprint server for health sciences

Published: June 26, 2025

Unique hematological presentation of patients with biallelic inactivation of FANCD1/BRCA2.

Unique hematological presentation of patients with biallelic inactivation of FANCD1/BRCA2.

Journal: Blood advances

Published: June 23, 2025

Opening of a phase Ib/II study to investigate the safety and efficacy of Afatinib in patients with Fanconi anemia and unresectable locally advanced or metastatic head and neck squamous cell carcinoma.

Opening of a phase Ib/II study to investigate the safety and efficacy of Afatinib in patients with Fanconi anemia and unresectable locally advanced or metastatic head and neck squamous cell carcinoma.

Journal: BMC cancer

Published: June 16, 2025

Comprehensive investigation of DNA damage repair genes in children with cancer identifies SMARCAL1 as novel osteosarcoma predisposition gene.

Comprehensive investigation of DNA damage repair genes in children with cancer identifies SMARCAL1 as novel osteosarcoma predisposition gene.

Journal: medRxiv : the preprint server for health sciences

Published: June 04, 2025

Pediatric high-grade gliomas in patients with neurofibromatosis type 1-A collaborative cohort study from the SIOPE HGG/DIPG working group.

Pediatric high-grade gliomas in patients with neurofibromatosis type 1-A collaborative cohort study from the SIOPE HGG/DIPG working group.

Journal: Neuro-oncology practice

Published: May 28, 2025

App supporting surveillance for (likely) pathogenic TP53 variant carriers: acceptance among a German cohort.

App supporting surveillance for (likely) pathogenic TP53 variant carriers: acceptance among a German cohort.

Journal: Archives of gynecology and obstetrics

Published: May 22, 2025

BRCA1-, BRCA2-, and PALB2-related Fanconi anemia: Scope to expand disease phenotypic features and predict breast cancer risk in heterozygotes.

BRCA1-, BRCA2-, and PALB2-related Fanconi anemia: Scope to expand disease phenotypic features and predict breast cancer risk in heterozygotes.

Journal: American journal of human genetics

Published: May 15, 2025

Showing 1-12 of 165

Last Updated: 09/26/2026